Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Celebrex

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Celebrex was produced by Pfizer.

Pfizer sales down but oncology shows promise

Pfizer sales down but oncology shows promise There were also gains for anti-inflammatory Celebrex (celecoxib), up 11 per cent to $752m, while fibromyalgia drug Lyrica (pregabalin) cemented its position as Pfizer's biggest-selling product with a

Pfizer sales dip as net income surges in Q2

Pfizer sales dip as net income surges in Q2 Epilepsy, neuropathic pain and fibromyalgia therapy Lyrica (pregabalin) cemented its position as Pfizer's biggest product with a 10 per cent gain to $1.13bn, while painkiller Celebrex (celecoxib) grew 10

GSK fires senior Chinese scientist over data fabrication

GSK fires senior Chinese scientist over data fabrication to faking dozens of research studies, including trials of Pfizer's Celebrex (celecoxib) and Merck &Co's Vioxx (rofecoxib).

Pfizer sues as Celebrex patent is reissued in US

Pfizer sues as Celebrex patent is reissued in US Court extends exclusivity of osteoarthritis treatment by 18 months. Pfizer has filed lawsuits against several generic drugmakers in the US after a key patent for its anti-inflammatory drug Celebrex was ... Celebrex (celecoxib) remains a major product for

Pfizer revenues decline in Q4 but profits surge

Pfizer revenues decline in Q4 but profits surge childhood vaccine Prevnar and anti-inflammatory Celebrex (celecoxib), which grew 22 per cent to $993m and 12 per cent to $750m, respectively.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics